Unraveling the mysteries of preeclampsia

American Journal of Obstetrics and Gynecology

Volumn 193, Issue 1, 2005, Pages 3-4

  Lindheimer, Marshall D ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC PROTEIN; BIOLOGICAL MARKER; DNA; MESSENGER RNA; PLACENTAL GROWTH FACTOR; PROTEIN TYROSINE KINASE; VASCULOTROPIN;

ANGIOGENESIS; DIABETES MELLITUS; EDITORIAL; GENE EXPRESSION; GENETICS; HUMAN; HYPERTENSION; METABOLIC DISORDER; METABOLISM; PATHOGENESIS; PLACENTA; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; PROTEINURIA; RISK FACTOR;

FEMALE; HUMANS; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY PROTEINS; PROTEINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 22244471078     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2005.03.017     Document Type: Editorial

References (5)

1. J.M. Davison M.D. Lindheimer New develops in preeclampsia Semin Nephrol 24 2004 537 625
2. M. Wolf, A. Shah, C. Lam, A. Martinez, K.V. Smirnakis, and F.H. Epstein Circulating levels of the antiangiogenic marker sFlt-1 are increased in first versus second pregnancies Am J Obstet Gynecol 192 2005 16 22
3. S.E. Maynard, J.Y. Min, J. Merchan, K.H. Lim, J. Li, and S. Mondal Excess soluble fibrin-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in women with preeclampsia J Clin Invest 111 2003 649 658
4. R.J. Levine, R. Thadhani, C. Qian, C. Lam, K.H. Lim, and K.F. Yu Urinary placental growth factor and risk of preeclampsia JAMA 293 2005 77 85
5. Unpublished workshop presentation at the XIV World Congress of the International Society for the Study of Hypertension in Pregnancy, Vienna, Austria, November 14-18, 2004.